Illumina Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AVGO | Broadcom | Outperform |
8
|
$1.29k | $1.21k | 19.74% | 11 | $558.29B |
| MRK | Merck | Outperform |
2
|
$130.72 | $130.51 | 7.10% | 11 | $321.69B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$571.73 | $591.94 | 7.57% | 1 | $218.24B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.26 | £165.99 | 34.72% | 16 | £186.43B |
| NOVN | Novartis | Hold |
10
|
CHF90.00 | CHF105.00 | 19.58% | 9 | CHF181.47B |
| ROG | Roche Holding | Hold |
16
|
CHF218.80 | CHF307.83 | 24.54% | 9 | CHF178.76B |
| DHR | Danaher | Outperform |
10
|
$245.80 | $260.33 | 9.85% | 4 | $182.06B |
| ABT | Abbott Laboratories | Outperform |
9
|
$106.86 | $118.92 | 18.38% | 7 | $186.15B |
| PFE | Pfizer | Outperform |
2
|
$25.26 | $32.87 | 20.74% | 6 | $147.23B |
| AMGN | Amgen | Outperform |
4
|
$269.38 | $303.65 | 17.77% | 8 | $144.25B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.70 | $58.15 | 21.92% | 10 | $90.60B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$65.27 | $87.82 | 22.57% | 14 | $81.39B |
| GSK | GSK | Outperform |
12
|
£16.41 | £17.30 | 18.83% | 12 | £65.34B |
| LONN | Lonza Group | Buy |
16
|
CHF513.80 | CHF516.89 | 13.86% | 8 | CHF37.70B |
| A | Agilent Technologies | Outperform |
10
|
$136.37 | $138.82 | 11.09% | 10 | $38.90B |
| DSFIR | DSM-Firmenich | Outperform |
18
|
102.70€ | 114.60€ | 16.85% | 0 | 27.62€B |
| LH | Laboratory Corp of America Hol... | Outperform |
11
|
$198.35 | $241.28 | 21.50% | 9 | $16.69B |
| SY1 | Symrise | Outperform |
18
|
99.92€ | 106.97€ | 11.09% | 5 | 14.73€B |
| BIM | bioMérieux | Outperform |
18
|
99.50€ | 105.55€ | 14.32% | 1 | 11.76€B |
| 500124 | Dr. Reddy's Laboratories | Hold |
18
|
Rp6.22k | Rp5.67k | -2.69% | 25 | Rp989.58B |
| 6869 | Sysmex | Outperform |
18
|
¥7.99k | ¥8.90k | 11.40% | 0 | ¥1.74T |
| EXAS | Exact Sciences | Buy |
8
|
$58.79 | $90.32 | 50.72% | 7 | $11.07B |
| NTRA | Natera | Outperform |
7
|
$91.28 | $74.41 | 12.84% | 8 | $10.30B |
| TECH | Bio-Techne Corp | Buy |
16
|
$62.66 | $100.78 | 27.67% | 2 | $9.76B |
| QGEN | QIAGEN N.V. | Outperform |
15
|
$41.08 | $0.00 | 21.71% | 3 | $8.89B |
| BIO | Bio-Rad Laboratories Inc | Buy |
16
|
$275.60 | $536.80 | 58.45% | 1 | $8.76B |
| CRDA | Croda International Plc | Outperform |
18
|
£46.49 | £65.12 | 9.70% | 6 | £6.49B |
| WCH | Wacker Chemie | Outperform |
17
|
101.85€ | 145.36€ | 22.73% | 9 | 5.06€B |
| CLN | Clariant | Outperform |
18
|
CHF13.02 | CHF16.11 | 15.21% | 6 | CHF4.33B |
| BIOCON | Biocon | Hold |
14
|
Rp291.65 | Rp270.86 | -9.14% | 14 | Rp312.41B |
| TNE | Technology One | Hold |
16
|
$16.12 | $16.29 | 2.36% | 12 | $5.52B |
| ALRM | Alarm.com Holdings | Outperform |
16
|
$65.23 | $67.13 | 26.63% | 7 | $3.20B |
| QDEL | Quidel Corp | Hold |
16
|
$39.69 | $121.00 | 34.04% | 6 | $2.94B |
| 1548 | Genscript Biotech | Buy |
5
|
HK$10.76 | HK$3.96 | -64.31% | 0 | HK$22.17B |
| AZTA | Azenta | Hold |
16
|
$51.50 | $58.50 | 24.27% | 5 | $2.82B |
| 300676 | BGI Genomics | - |
17
|
¥38.92 | ¥0.00 | -100.00% | 0 | ¥18.44B |
| PENN | PENN Entertainment | Outperform |
13
|
$17.19 | $29.89 | 45.43% | 1 | $2.47B |
| TWST | Twist Bioscience | Outperform |
4
|
$31.08 | $34.00 | 33.53% | 2 | $2.40B |
| GH | Guardant Health | Buy |
6
|
$17.16 | $43.00 | 156.41% | 2 | $2.36B |
| NEO | NeoGenomics | Outperform |
8
|
$13.85 | $20.09 | 44.40% | 9 | $1.90B |
| PACB | Pacific Biosciences of Califor... | Outperform |
9
|
$1.38 | $12.67 | 153.62% | 4 | $1.78B |
| MYGN | Myriad Genetics | Hold |
6
|
$17.98 | $22.08 | 39.04% | 8 | $1.67B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
| QTRX | Quanterix | Outperform |
11
|
$15.59 | $32.00 | 105.26% | 0 | $906.40M |
| 000710 | Berry Genomics Co.,Ltd | - |
10
|
¥7.23 | ¥56.76 | -100.00% | 0 | ¥5.09B |
| FLGT | Fulgent Genetics | Hold |
16
|
$20.03 | $31.50 | 24.81% | 2 | $693.56M |
| LAB | Standard BioTools | Buy |
11
|
$2.36 | $4.00 | 48.31% | 1 | $686.85M |
| ADPT | Adaptive Biotechnologies | Outperform |
6
|
$2.61 | $8.67 | 129.89% | 2 | $570.40M |
| CEVI | CellaVision AB (publ) | Outperform |
16
|
kr229.50 | kr191.75 | 6.75% | 3 | kr5.47B |
| GLAXO | GlaxoSmithKline Pakistan | - |
18
|
₨79.00 | ₨0.00 | -100.00% | 0 | ₨37.46B |
| MACAY | Macay Holdings | - |
16
|
Php6.90 | Php0.00 | -100.00% | 0 | Php7.61B |
| PSNL | Personalis | Outperform |
6
|
$1.25 | $4.45 | 220.00% | 3 | $71.59M |
| IMMNOV | Immunovia AB (publ) | - |
0
|
kr1.94 | kr0.00 | -100.00% | 0 | kr747.75M |
| HEALTH | Nightingale Health Oyj | Outperform |
2
|
1.95€ | 1.10€ | -35.90% | 1 | 61.31€M |
| BNGO | Bionano Genomics | Outperform |
6
|
$0.76 | $12.33 | 689.47% | 2 | $44.28M |
| AGL | ANGLE | Buy |
8
|
£0.14 | £0.97 | 392.86% | 0 | £32.56M |
| TTOO | T2 Biosystems | - |
6
|
$2.74 | $8.68 | -100.00% | 0 | $24.09M |
| CNTG | Centogene N.V. | Outperform |
8
|
$0.48 | $1.37 | 187.50% | 0 | $23.96M |
| AXDX | Accelerate Diagnostics | Buy |
8
|
$0.95 | $5.00 | -100.00% | 1 | $21.49M |
| FRES | Fresh2 Group | - |
0
|
$0.39 | $0.00 | -100.00% | 0 | $20.50M |
| NSTG | NanoString Technologies | - |
7
|
$0.29 | $5.02 | -100.00% | 4 | $9.62M |
| PRPO | Precipio | - |
0
|
$6.18 | $19.00 | -100.00% | 1 | $9.44M |
| OPGN | OpGen |
2
|
$0.53 | $3.00 | -100.00% | 1 | $4.61M | |
| NVTA | Invitae | - |
4
|
$0.00 | $0.71 | 0.00% | 8 | $3.18M |
| ECX | Epigenomics | Buy |
6
|
1.61€ | 52.65€ | 946.58% | 1 | 1.57€M |
| BIOC.Q | Biocept | Hold |
-16
|
$0.00 | $8.00 | 0.00% | 0 | $0.13M |
| ARYC | Arrayit | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.11M |
| HTGM.Q | HTG Molecular Diagnostics | - |
6
|
$0.00 | $6.00 | 0.00% | 1 | $0.00M |